Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension

Characterization of toxin-induced mouse models of regressive liver disease, focusing on the detecting of a suitable therapeutic window during fibrosis and portal hypertension (PH) regression. C57BL/6JRj mice were studied when exposed to thioacetamide (TAA) or carbon tetrachloride (CCl 4 ) for 8 or 12 weeks (8w/12w) and after one/two (+R1/+R2) week(s) of TAA/CCl 4 -free regression. Healthy controls received NaCl or olive oil (OO). Primary readouts included liver fibrosis (collagen proportionate area, CPA), portal pressure (PP), serum transaminases and hepatic fibrosis-related gene expression. The diseased models (8wTAA/12wTAA/8wCCl 4 /12wCCl 4 ) showed significant fibrosis (CPA: 3.03/3.87/8.53/16.90%; vs. NaCl/OO: 0.87/1.15%) and PH (PP: 6.8/7.7/8.5/10.0 mmHg; vs. NaCl/OO: 5.5/5.1 mmHg). CPA significantly regressed in 8wTAA+R1 (2.60%; p = 0.01) and 12wCCl 4 +R1 (10.9%; p = 0.01), but not in 12wTAA+R1/8wCCl 4 +R1. CPA regression was significant in all +R2-groups ( p < 0.001) but not in 8wCCl 4 +R2 ( p = 0.30). Significant PP regression was found at 8wCCl 4 +R1 (5.8 mmHg; p = 0.004) and 12wCCl 4 +R1 (8.4 mmHg; p = 0.01), but not in the 8w/12w TAA models. All +R2-groups showed significant PP regression: 8wTAA+R2 (6.0 mmHg; p ≤ 0.001), 12wTAA+R2 (6.0 mmHg), 8wCCl 4 +R2 (6.0 mmHg, p = 0.004) and 12wCCl 4 +R2 (7.9 mmHg, p = 0.008). Serum AST/ALT levels at +R1/+R2 returned to levels of healthy controls. Hepatic Col1a1 and Timp1 gene expression peaked in 12w-groups and showed a gradual decrease at +R1/+R2: Col1a1 (12wTAA+R1/+R2: -14%/-29%, p = 0.002; 12wCCl 4 +R1/R2: -28%/-23%, p = 0.05) and Timp1 (12wTAA+R1/+R2: -41%/-61%, p ≤ 0.001; 12wCCl 4 +R1/R2: -43%/-40%, p ≤ 0.001). While liver disease regressed in all models/timepoints, both liver fibrosis (CPA) and PP remained increased in the 12wCCl 4 +R1/R2 settings – qualifying this model as suitable for pre-clinical testing of therapeutic strategies aimed at promoting liver fibrosis and PH regression.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-06-14
DOI
https://doi.org/10.1038/s41598-026-54627-5
Primary Topic
Liver physiology and pathology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension

Stefan G. Kauschke, Tatjana Stojaković, Larissa Pfisterer, Philipp Königshofer et al.
Scientific Reports
Liver physiology and pathology
article

Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension

Stefan G. Kauschke, Tatjana Stojaković, Larissa Pfisterer, Philipp Königshofer, Ksenia Brusilovskaya, Thomas Sorz, Benedikt Simbrunner, Vlad Țâru, Philipp Schwabl, Hubert Scharnagl, Katharina Regnat, Katharina Bonitz, Oleksandr Petrenko, Thomas Reiberger, Benedikt Silvester Hofer, Michael A Trauner, Katharina Bareiner, Kerstin Zinober
article en

Abstract

Characterization of toxin-induced mouse models of regressive liver disease, focusing on the detecting of a suitable therapeutic window during fibrosis and portal hypertension (PH) regression. C57BL/6JRj mice were studied when exposed to thioacetamide (TAA) or carbon tetrachloride (CCl 4 ) for 8 or 12 weeks (8w/12w) and after one/two (+R1/+R2) week(s) of TAA/CCl 4 -free regression. Healthy controls received NaCl or olive oil (OO). Primary readouts included liver fibrosis (collagen proportionate area, CPA), portal pressure (PP), serum transaminases and hepatic fibrosis-related gene expression. The diseased models (8wTAA/12wTAA/8wCCl 4 /12wCCl 4 ) showed significant fibrosis (CPA: 3.03/3.87/8.53/16.90%; vs. NaCl/OO: 0.87/1.15%) and PH (PP: 6.8/7.7/8.5/10.0 mmHg; vs. NaCl/OO: 5.5/5.1 mmHg). CPA significantly regressed in 8wTAA+R1 (2.60%; p = 0.01) and 12wCCl 4 +R1 (10.9%; p = 0.01), but not in 12wTAA+R1/8wCCl 4 +R1. CPA regression was significant in all +R2-groups ( p < 0.001) but not in 8wCCl 4 +R2 ( p = 0.30). Significant PP regression was found at 8wCCl 4 +R1 (5.8 mmHg; p = 0.004) and 12wCCl 4 +R1 (8.4 mmHg; p = 0.01), but not in the 8w/12w TAA models. All +R2-groups showed significant PP regression: 8wTAA+R2 (6.0 mmHg; p ≤ 0.001), 12wTAA+R2 (6.0 mmHg), 8wCCl 4 +R2 (6.0 mmHg, p = 0.004) and 12wCCl 4 +R2 (7.9 mmHg, p = 0.008). Serum AST/ALT levels at +R1/+R2 returned to levels of healthy controls. Hepatic Col1a1 and Timp1 gene expression peaked in 12w-groups and showed a gradual decrease at +R1/+R2: Col1a1 (12wTAA+R1/+R2: -14%/-29%, p = 0.002; 12wCCl 4 +R1/R2: -28%/-23%, p = 0.05) and Timp1 (12wTAA+R1/+R2: -41%/-61%, p ≤ 0.001; 12wCCl 4 +R1/R2: -43%/-40%, p ≤ 0.001). While liver disease regressed in all models/timepoints, both liver fibrosis (CPA) and PP remained increased in the 12wCCl 4 +R1/R2 settings – qualifying this model as suitable for pre-clinical testing of therapeutic strategies aimed at promoting liver fibrosis and PH regression.

Scientific Reports
Boehringer Ingelheim (Germany) (DE), Austrian Academy of Sciences (AT), Medical University of Graz (AT), Graz University Hospital (AT), Christian Doppler Laboratory for Thermoelectricity (AT), CeMM Research Center for Molecular Medicine (AT), Medical University of Vienna (AT)
Boehringer Ingelheim, Christian Doppler Forschungsgesellschaft
Good health and well-being
Openalex Percentile: Top 7%
Liver physiology and pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.